6280 J . Org. Chem., Vol. 61, No. 18, 1996
Thomson et al.
amidite) (420 mg, 500 µmol) and S8 dissolved in CS2/pyridine
(1:1) for oxidation to give 2 (2540 A260 units, 254 µmol, 51%):
31P NMR (D2O) 44.45 ppm; MS m/z 338.020 500, calcd for
C9H13N3O7P1S1 338.021 185.
2′-Am in o-2′-d eoxyu r id ylyl (3′-5′) 5′-Th io-5′-d eoxyu r i-
d in e (a m Up sU). This was prepared by the same method
described for 2′-O-(tert-butyldimethylsilyl)uridylyl (3′-5′) 5′-
thio-5′-deoxyuridine but using compound 2 (500 A260 units, 50
µmol), tri-n-butylamine (36 µL, 3 equiv), and 5′-iodo-5′-
deoxyuridine (35 mg, 2 equiv, 100 µmol) to give amUpsU (496
A260 units, 24.8 µmol, 49.6%): 31P NMR (D2O) 20.16 ppm; MS
m/z 564.079 086, calcd for C18H23N5O12S1P1 564.080 157.
Th ym id in e (3′-5′) 5′-Th io-5′-d eoxyth ym id in e (Tp sT).
This was prepared by the same method described for amUpsU
but using thymidine 3′-thiomonophosphate (125 A267 units,
12.5 µmol), tri-n-butylamine (9 µl, 3 equiv), and 5′-iodo-5′-
deoxythymidine (9 mg, 2 equiv 25 µmol) to give TpsT (125 A267
units, 6.8 µmol, 50%): 31P NMR (D2O) 19.80 ppm; MS m/z 561
(M - H+).
indicated that the reaction had gone to 90% completion [(buffer
system 1, gradient 2,) tR (UpnU) 8 min, tR (5), 25 min].
Purification was carried out by preparative HPLC (buffer
system 2, gradient 1), and the appropriate fractions were
collected and frozen before being combined and lyophilized to
yield UpnU as a white solid containing ca. 10% 2′,3′cUMP.
The reaction product was dissolved in H2O (2 mL) and stored
at -20 °C (225 A260 units, 11.3 µmol, 75%): 31P NMR (D2O)
9.29 (s), [cUMP 20.83 (s)]; MS m/z 548.101 456, calcd for
C18H23N5O13P1 548.103 000.
(Rp /Sp )-5′-O-(4,4′-Dim eth oxytr ityl)-2′-d eoxy-2′-(tr iflu o-
r oa cet a m id o)u r id ylyl (3′-5′) 5′-Am in o-5′-d eoxyt h ym i-
d in e Meth yl Ester (6). This was prepared by the same
method described for compound
3 but using 5′-O-(4,4′-
dimethoxytrityl)-2′-deoxy-2′-(trifluoroacetamido)uridine (1.364
g, 2.12 mmol) dissolved in CH2Cl2:CH3CN (1:1, v/v, 40 mL),
tetrazole (0.5 M, 6.36 mL, 1.5 eq), (N,N′-diisopropylamino)-
dimethoxyphosphane (0.613 g, 3.18 mmol, 1.5 eq), LiCl (0.445
g, 10.6 mmol, 5 eq), and 5′-azido-5′deoxythymidine (0.566 g,
2.12 mmol, 1 eq). The reaction mixture was concentrated in
vacuo twice from toluene (2 × 10 mL), and the residue was
dissolved in EtOAc (300 mL) and subsequently washed with
5% NaHCO3 (100 mL) and NaCl (saturated 100 mL), dried
(Na2SO4), filtered, and evaporated to dryness. The crude
product was purified by silica gel chromatography followed by
preperative HPLC to give 6 (8060 A260 unit 403 µmol, 19%):
31P NMR (CD3OD) 12.58 (s) and 12.66 (s), 1:1; MS m/z
957.268 193, calcd for C43H46N6O14P1F3 957.268 349.
5′-O-(4,4′-Dim et h oxyt r it yl)-2′-d eoxy-2′-(t r iflu or oa cet -
a m id o)u r id ylyl (3′-5′) 5′-Am in o-5′-d eoxyth ym id in e (7).
This was prepared by the same method as described for
compound 4 but starting with compound 6 to give 7 (89%):
31P NMR (CD3OD) 8.5; MS m/z 943.255 030, calcd for
C42H44N6O14P1F3 943.2526 992.
(Rp /Sp )-5′-O-(4,4′-Dim et h oxyt r it yl)-2′-O-(ter t-b u t yld i-
m et h ylsilyl)u r id ylyl (3′-5′)-5′-Am in o-5′-d eoxyu r id in e
Meth yl Ester (3). 5′-O-(4,4′-Dimethoxytrityl)-2′-O-(tert-bu-
tyldimethylsilyl)uridine (1.336 g, 2 mmol) was dissolved in dry
CH2Cl2/CH3CN (10:7, v/v, 17 mL), and the flask was sealed
with a septum and flushed with argon. To this was then added
a solution of tetrazole dissolved in CH3CN (0.5 M, 3 mL, 0.75
equiv) and (N,N′-diisopropylamino)dimethoxyphosphane (0.404
g, 2.09 mmol, 1.05 equiv), and the solution was stirred for 4 h
at room temperature. With maintenance of the argon atmo-
sphere, anhydrous ether (50 mL) was then added and the
resultant white precipitate removed by filtration. The super-
natant was concentrated in vacuo and the residue dissolved
in anhydrous pyridine (5 mL). To this solution was added LiCl
(0.420 g, 10 mmol, 5 equiv) followed by 5′-azido-5′-deoxyuridine
(0.875 g, 3.25 mmol, 1.62 equiv), and the reaction mixture was
stirred for 20 h at room temperature, Rf (product) 0.25 (solvent
C). The crude product was then concentrated, in vacuo, and
purified by silica gel column chromatography, eluting with
CH2Cl2 (0%-10% MeOH) containing triethylamine (1%), fol-
lowed by preparative HPLC [(buffer system 2, gradient 3) tR
(3) 16 min, tR (5′-azido-5′-deoxyuridine) 6 min] to yield 3 (5560
A260 units, 278 µmol, 14%). 31P NMR (CD3OD) 12.30 (s) and
12.66 (s), 1:1; m/z 978.336 304, calcd for C46H57N5O15P1Si1
978.335 809.
5′-O-(4,4′-Dim eth oxytr ityl)-2′-O-(ter t-bu tyld im eth ylsi-
lyl)u r id yl (3′-5′) 5′-Am in o-5′-d eoxyu r id in e (4). Compound
3 (1000 A260 units, 50 µmol), in MeOH (1.8 mL), was evapo-
rated to dryness and evaporated twice from dioxane (0.5 mL).
To this residue was then added a solution of thiophenol/
triethylamine/dioxane (1:2:3, v/v, 6 mL) and the resulting
solution stirred at room temperature for 24 h; TLC (solvent
D) Rf (4) 0.4, Rf (3) 0.68. The reaction mixture was concen-
trated in vacuo, the residue was twice evaporated from MeOH
(2 mL), and the crude product was purified by silica gel
chromatography, eluting with CH2Cl2 (0%-10% MeOH) con-
taining triethylamine (1%), to yield 4 (871 A260 units, 43.5
µmol, 87%): 31P NMR (CD3OD) 8.4; MS m/z 964.320 159, calcd
for C45H55N5O15P1Si1 964.320 159.
2′-O-(ter t-Bu tyld im eth ylsilyl)u r id ylyl (3′-5′) 5′-Am in o-
5′-d eoxyu r id in e (5). To 4 (600 A260 units, 30 µmol) was added
acetic acid (80%, 200 µL) and the solution was thoroughly
shaken by vortexing. After 6 min, removal of DMTr was
quantitative by HPLC [(buffer system 1, gradient 2) tR (5) 17
min, tR (4) 25 min] and the reaction mixture was cooled in an
ice bath and brought to pH 7 by addition of NaOH (1.2 mL, 2
M). The reaction mixture was purified by chromatography
over DEAE-Sephadex A-25 eluted with a linear gradient of
TEAB (0 to 0.5M, total volume 1 l) to yield 5 (340 A260 units,
17 µmol, 57%): 31P NMR (CD3OD) 9.74; MS m/z 662.188 828,
calcd for C24H37N5O113P1Si1 662.189 479.
Ur id ylyl (3′-5′) 5′-Am in o-5′-d eoxyu r id in e Up n U. Com-
pound 5, dissolved in H2O (0.9 mL) (300 A260 units, 15 µmol),
was evaporated to dryness, the residue evaporated twice from
THF (500 µL), TBAF (500 µL, 1.1 M) added, and the solution
incubated for 16 h at rt. Subsequent analytical HPLC
2′-Deoxy-2′-(t r iflu or oa cet a m id o)u r id ylyl (3′-5′) 5′-
Am in o-5′-d eoxyth ym id in e (8). This was prepared by the
same method as described for compound 5 but starting with
compound 7 to give 8 (93%): 31P NMR (CD3OD) 9.71; MS m/z
641.122 494, calcd for C21H26N6O12P1F3 641.122 019
2′-Am in o-2′-d eoxyu r id ylyl (3′-5′) 5′-Am in o-5′-d eoxy-
th ym id in e (a m Up n T). To a solution of compound 8 in MeOH
(600A260 units, 30 µmol, 1 mL) was added Na2CO3 (10%, H2O/
MeOH 8:2, v/v, 6 mL), and the mixture was stirred for 8 h at
rt. Subsequent analytical HPLC indicated that the reaction
had gone to 80% completion; (buffer system 1, gradient 1,) tR
(amUpnT) 10.55 min, tR (8), 15.2 min. Purification was carried
out by preparative HPLC (buffer system 2, gradient 1), and
the appropriate fractions were collected and frozen before being
combined and lyophilized to yield amUpnT as a white solid
contaminated with ca. 12% of cyclic phosphoramidate (12). The
product was dissolved in H2O (2 mL) and stored at -20 °C
(380 A260 units, 19 µmol, 63%): 31P NMR (D2O + H2O, pH 12)
9.04 (s), [28.8, s, cUMnP; 7.69, s, 2′-amino-2′-deoxyuridine 2′-
monophosphoramidate].
2′-Am in o-2′-d eoxyu r id in e 3′-Mon op h osp h a te (9). 5′-
(4,4′-Dimethoxytrityl)-2′-deoxy-2′-(trifluoroacetamido)-2′-
deoxyuridine 3′-O-(â-cyanoethyl N,N-diisopropylphosphoram-
idite) (210 mg, 250 µmol) was dissolved in anhydrous CH3CN
(3 mL) under an argon atmosphere. A solution of tetrazole in
acetonitrile (0.5 M, 0.75 mL, 1.25 equiv) and 3-hydroxypropi-
onitrile (20.38 µL, 1.2 eq) was then added and the mixture
stirred at room temperature for 1.5 h. A solution of iodine
(0.5 M, ca. 0.8 mL) in THF/pyridine/H2O (7:2:1) was added
dropwise to the reaction mixture until the color persisted, and
stirring was continued for a further 30 min. NaHSO3 (5%,
1.2 mL) was then added and the solution concentrated in
vacuo. The residue was then dissolved in H2O (50 mL) and
extracted with CH2Cl2 (2 × 50 mL), and the organic phase was
dried (Na2SO4), filtered, and evaporated to dryness. Removal
of the protecting groups was performed as described for the
synthesis of 2 to give compound 9 (1035 A260 units, 103 µmol,
41%): 31P NMR (D2O) 4.16 (d) J PH ) 8.24 Hz; MS m/z
322.043 045 (M - H)- calcd for C9H14N3O8.P1 322.044 028.
Abbr evia tion s: HEPES, N-2-hydroxyethylpiperazine-N′-
2-ethanesulfonic acid; MOPS, 3-(N-morpholino)propanesulfonic